Biểu đồ giá cổ phiếu VACBF
VACBF Thu nhập
Nykode Therapeutics AS
$0.32
0%
$0
Khi đóng cửa: Jun 18, 16:00:00 GMT-4
$0.32
0%
$0
Phiên trước giờ: Jun 22, 06:51:57 GMT-4
Quay lại
Nykode Therapeutics AS (VACBF) Thu nhập
Thống kê chính
Giá đóng cửa trước
$0.3247
Giá mở cửa
$0.3631
Phạm vi ngày
$0.3247 - $0.3631
Phạm vi 52 tuần
$0.1557 - $0.38
Khối lượng
1.0K
Khối lượng trung bình
32
Tỷ suất cổ tức
--
EPS (TTM)
-0.05
Vốn hóa thị trường
$106.0M
NYKODE THERAPEUTICS ASA là gì?
Nykode Therapeutics ASA is a clinical-stage biopharmaceutical company which engages in discovering and developing of novel immunotherapies. The company employs 59 full-time employees The company went IPO on 2020-01-27. Nykode uses its vaccine technology platform to generate therapeutics in disease indications with unmet medical need. The firm develops next generation vaccines for clinical use, based on a deep understanding of immunological principles. Nykode Therapeutics’ main product candidates are VB10.16 and VB10.NEO. VB10.16 is a therapeutic cancer vaccine against HPV16-related cancers. VB10. NEO is a therapeutic cancer neoantigen vaccine. The firm also has two universal COVID-19 vaccine candidates in development.
